BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2008
View Archived Issues
Further clinical study of MK-7009 to follow evaluation in healthy volunteers
Read More
Anti-HCV activity of R-7128 seen in different races/ethnicities
Read More
Takeda updates key milestones of first half of 2008
Read More
Novel dual CB1/CB2 receptor agonist efficacious in experimental pain models
Read More
Helsinn Healthcare and Zealand Pharma partner for ZP-1846
Read More
ProStrakan grants license to Bayer Schering for Tostran testosterone treatment
Read More
Prana provides update on research and development programs
Read More
GFT-505 shows beneficial effect on plasma lipids
Read More
Novel agents for cardiovascular disorders disclosed in recent CTG Pharma patent
Read More
Streptococcal endopeptidase IdeS prevents experimental glomerulonephritis
Read More
Recent patents describe new treatment options for thrombotic disorders
Read More
ONO-1301MS may improve tubulointerstitial injury in chronic kidney disease
Read More
Novel antiinflammatory agents jointly claimed by Boehringer Ingelheim and Biolipox
Read More
Phase II chronic plaque psoriasis study with ALT-2074 currently enrolling patients
Read More
Positive results reported for novel HDAC inhibitor in experimental Huntington's disease in mice
Read More
Ark files MAA with EMEA for Cerepro for malignant glioma
Read More
FDA accepts Cell Therapeutics' Zevalin sBLA and grants priority review
Read More
FDA approves Duramed's synthetic conjugated estrogens-A cream
Read More
Quintiles acquires Targeted Molecular Diagnostics
Read More
Lexicon files IND with the FDA for LX-4211 as a potential treatment for diabetes
Read More
Paladin and GSK sign 3-year distribution agreement for Dexedrine for ADHD
Read More
TorreyPines reports results from study of NGX-426 in capsaicin-induced pain
Read More
ANA-598 receives FDA fast track designation for chronic hepatitis C infection
Read More
FDA grants orphan drug designation to pralatrexate for follicular lymphoma
Read More
ViroPharma submits sBLA for Cinryze for hereditary angioedema
Read More
